logo
logo
logo
logo

logo

HOME/ PUBLICATIONS/PATENTS

Publications / Patents >
2026 >
2025 >
2024 >
2023 >
2022 >
2021 >
2020 >
2019 >
2018 >
2017 >
2016 >
2015 >
2014 >
2013 >
2012 >
2011 >
2010/2009 >
Patents >
Book Chapters >

Publications in 2023

Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...


  1. Laxmikeshav, K.; Rahman, Z.; Mahale, A.; Valapil, D. G.; Sharma, P.; George, J.; Phanindranath, R.; Dandekar, M. P.; Kulkarni, O.; Nagesh, N.; Shankaraiah, N. Benzimidazole Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis and In Vitro Cytotoxicity Studies. Bioorganic & Medicinal Chemistry Letters 2023, 96, 129494. https://doi.org/10.1016/j.bmcl.2023.129494
  2. Valapil, D. G.; Mishra, P.; Jungare, K.; Shankaraiah, N. Ru(II)-Catalyzed Synthesis of Indolo[2,3-c]isoquinolines via [3+3] Annulation of N,N′-Cyclic Azomethine Ylides and 3-Diazoindolin-2-imines. New Journal of Chemistry 2023, 47, 17586–17591. https://doi.org/10.1039/d3nj03009a
  3. Dhurjad, P.; Gupta, K.; Sakla, A. P.; Shankaraiah, N.; Sonti, R. A Validated High-Performance Liquid Chromatography Method for Determination of Brassinin, an Indoleamine 2,3-Dioxygenase Inhibitor in Rat Plasma. Separation Science Plus 2023, 6, 2300073. https://doi.org/10.1002/sscp.202300073
  4. Sana, S.; Dannarm, S. R.; Tokala, R.; Dastari, S.; Sathish, M.; Kumar, R.; Sonti, R.; Shankaraiah, N. Sustainable Photocatalytic C−H Annulation of Heteroarenes with Sulfoxonium Ylides: Synthesis and Photophysical Properties of Fused Imidazo[1,2-a]pyridine Based Molecules. Organic Chemistry Frontiers 2023, 10, 4800–4808. https://doi.org/10.1039/d3qo00923h
  5. Sana, S.; Dastari, S.; Reddy, D. S.; Tokala, R.; Sathish, M.; Sonti, R.; Shankaraiah, N. Visible-Light-Mediated Photocatalytic Sequential N-Arylation: An Eco-Friendly Synthetic Route to Unsymmetrical Di-Arylamines and Imatinib Drug. Organic Chemistry Frontiers 2023, 10, 4573–4580. https://doi.org/10.1039/d3qo00894k
  6. Soni, J. P.; Valapil, D. G.; Joshi, S. V.; Shankaraiah, N. Reminiscing the Microwave-Assisted Chemistry of 5- and 6-Membered Benzene-Fused N-Heterocycles. Arkivoc 2023, (vi), 202311928. https://doi.org/10.24820/ark.5550190.p011.928
  7. Soni, J. P.; Devi, P.; Chemitikanti, S.; Sharma, A.; Swamy, C. V. D.; Phanindranath, R.; Sathish, M.; Nagesh, N.; Godugu, C.; Shankaraiah, N. Design, Synthesis and In Vitro Cytotoxic Evaluation of β-Carboline Tethered Quinoline-4-Carboxamide Conjugates as DNA-Interactive Topo II Inhibitors. Journal of Molecular Structure 2023, 1291, 136001. https://doi.org/10.1016/j.molstruc.2023.136001
  8. Sakla, A. P.; Panda, B.; Mahale, A.; Sharma, P.; Laxmikeshav, K.; Khan, M. A.; Kulkarni, O. P.; Godugu, C.; Shankaraiah, N. Regioselective Synthesis and In Vitro Cytotoxicity Evaluation of 3-Thiooxindole Derivatives: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. Bioorganic & Medicinal Chemistry 2023, 90, 117297. https://doi.org/10.1016/j.bmc.2023.117297
  9. Thatikonda, S.; Tokala, R.; Pooladanda, V.; Shankaraiah, N.; Godugu, C. Niclosamide Inhibits Epithelial-Mesenchymal Transition with Apoptosis Induction in BRAF/NRAS Mutated Metastatic Melanoma Cells. Toxicology In Vitro 2023, 89, 105579. https://doi.org/10.1016/j.tiv.2023.105579
  10. Tangella, Y.; Soni, J. P.; Shankaraiah, N.; Abril, D.; Sathish, M. Trimethylsilyl Azide-Promoted Acid-Amine Coupling: A Facile One-Pot Route to Amides from Carboxylic Acids and Amines. Arkivoc 2023, (vi), 202211914. https://doi.org/10.24820/ark.5550190.p011.914
  11. Soni, J. P.; Chilvery, S.; Sharma, A.; Reddy, G. N.; Godugu, C.; Shankaraiah, N. Design, Synthesis and In Vitro Cytotoxicity Evaluation of Indolo-Pyrazoles Grafted with Thiazolidinone as Tubulin Polymerization Inhibitors. RSC Medicinal Chemistry 2023, 14, 549–562. https://doi.org/10.1039/d2md00442a
  12. Bora, D.; Samir, K. M.; Sharma, A.; Chilvery, S.; Bansod, S.; John, S. E.; Godugu, C.; Shankaraiah, N. Exploration of Cytotoxic Potential and Tubulin Polymerization Inhibition Activity of cis-Stilbene-1,2,3-Triazole Congeners. RSC Medicinal Chemistry 2023, 14, 482–490. https://doi.org/10.1039/d2md00400c
  13. John, S. E.; Sharma, A.; Gulati, S.; Bora, D.; Shankaraiah, N. Synthesis of cis-Stilbene Based 1,2,4-Triazole/1,3,4-Oxadiazole Conjugates as Potential Cytotoxic and Tubulin Polymerization Inhibitors. New Journal of Chemistry 2023, 47, 4687–4697. https://doi.org/10.1039/d2nj04955d
  14. Laxmikeshav, K.; Sayali, M.; Devabattula, G.; Sharma, P.; Mahale, A.; George, J.; Phanindranath, R.; Godugu, C.; Kulkarni, O. P.; Nagesh, N.; Shankaraiah, N. 1,2,3-Triazolo-2-Aryl-Linked Benzimidazole Derivatives as Tubulin Polymerization Inhibitors and DNA Intercalators: Design, Synthesis, Biological Evaluation and Docking Studies. Archiv der Pharmazie 2023, 356, 2200449. https://doi.org/10.2139/ssrn.4115545
  15. Soni, J. P.; Reddy, G. N.; Rahman, Z.; Sharma, A.; Spandana, A.; Phanindranath, R.; Dandekar, M. P.; Nagesh, N.; Shankaraiah, N. Synthesis and Cytotoxicity Evaluation of DNA-Interactive β-Carboline Indolyl-3-Glyoxamide Derivatives: Topo-II Inhibition and In Silico Modelling Studies. Bioorganic Chemistry 2023, 131, 106313. https://doi.org/10.1016/j.bioorg.2022.106313
  16. Bora, D.; Sharma, A.; John, S. E.; Shankaraiah, N. Development of Hydrazide Hydrazone-Tethered Combretastatin-Oxindole Derivatives as Antimitotic Agents. Journal of Molecular Structure 2023, 1275, 134675. https://doi.org/10.1016/j.molstruc.2022.134675
  17. Laxmikeshav, K.; Sharma, P.; Palepu, M.; Sharma, P.; Mahale, A.; George, J.; Phanindranath, R.; Dandekar, M. P.; Kulkarni, O. P.; Nagesh, N.; Shankaraiah, N. Benzimidazole Based Bis-Carboxamide Derivatives as Promising Cytotoxic Agents: Design, Synthesis, In Silico and Tubulin Polymerization Inhibition. Journal of Molecular Structure 2023, 1271, 134078. https://doi.org/10.1016/j.molstruc.2022.134078
  18. Kushwah, B. S.; Thummar, M. M.; Yadav, A. S.; Dhiman, V.; Samanthula, G. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC–MS/MS. Biomedical Chromatography 2023, 37 (1), e5517. https://doi.org/10.1002/bmc.5517
  19. Kushwah, B. S.; Singh, S.; Thummar, M. M.; Balhara, A.; Samanthula, G. Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time-of-flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™. Rapid Communications in Mass Spectrometry 2023, 37 (1), e9415. https://doi.org/10.1002/rcm.9415
  20. Golla, V. M.; Kushwah, B. S.; Dhiman, V.; Velip, L.; Samanthula, G. LC-HRMS and NMR studies for characterization of forced degradation impurities of ponatinib, a tyrosine kinase inhibitor, insights into in-silico degradation and toxicity profiles. Journal of Pharmaceutical and Biomedical Analysis 2023, 227, 115280. https://doi.org/10.1016/j.jpba.2023.115280
  21. Dhiman, V.; Chavan, B. B.; Ramarapu, N.; Samanthula, G. Insight into in silico prediction and chemical degradation study of osimertinib mesylate by LC-HRMS and NMR: Investigation of a typical case of alkaline pH-mediated oxidative degradation product. European Journal of Mass Spectrometry 2023, 29 (2), 123–131. https://doi.org/10.1177/14690667231162345
  22. Kommalapati, H. S.; Pilli, P.; Samanthula, G. Green sample preparation in bioanalysis: where are we now? Bioanalysis 2023, 15, 363–366. https://doi.org/10.4155/bio-2023-0062
  23. Dhiman, V.; Ahirwar, S.; Chaganti, S.; Gananadhamu, S. Photolytic and oxidative degradation behavior of anticancer drug venetoclax: characterization of new degradation products using high resolution mass spectrometry. Journal of Analytical Chemistry 2023, 78 (4), 522–534. https://doi.org/10.1134/S1061934823040081
  24. Tidke, M.; Golla, V. M.; Kushwah, B. S.; Naik, D. D.; Gananadhamu, S. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance. Biomedical Chromatography 2023, 37 (8), e5636. https://doi.org/10.1002/bmc.5636
  25. Velip, L.; Dhiman, V.; Kushwah, B. S.; Samanthula, G. Characterization of degradation products and drug–excipient interaction products of erdafitinib by LC–Q-TOF-MS/MS and NMR. Chromatographia 2023, 86 (8), 627–638. https://doi.org/10.1007/s10337-023-04268-x
  26. Chaganti, S.; Dhiman, V.; Madhyanapu Golla, V.; KR, R.; Khemchandani, R.; Samanthula, G. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Rapid Communications in Mass Spectrometry 2023, 37 (18), e9605. https://doi.org/10.1002/rcm.9605
  27. Sree Kommalapati, H.; Pilli, P.; Golla, V. M.; Bhatt, N.; Samanthula, G. In silico tools to thaw the complexity of the data: revolutionizing drug research in drug metabolism, pharmacokinetics and toxicity prediction. Current Drug Metabolism 2023, 24 (11), 735–755. https://doi.org/10.2174/0113892002270798231201111422
  28. Joga, R.; Kannan, B.; Yerram, S.; Nandagawale, A.; Gawai, M.; Behera, H. K.; Kumar, N.; Grover, P.; Srivastava, S.; Monga, G.; Kumar, S. Transethosome as a Versatile Nano Vehicle for Various Indications and Its Regulatory Insights. Pharmaceutical Development and Technology 2023, 28, 1056–1078. https://doi.org/10.1080/10837450.2023.2289127
  29. Bellapu, K. K.; Joga, R.; Kannan, B. R.; Yerram, S.; Varpe, P.; Mergu, T.; Vasu, P. Y.; Srivastava, S.; Kumar, S. Lipid-Based Mesoporous Silica Nanoparticles: A Paradigm Shift in Management of Pancreatic Cancer. Pharmaceutical Patent Analyst 2023, 12, 261–273. https://doi.org/10.4155/ppa-2023-0024
  30. Shah, S.; Joga, R.; Kolipaka, T.; Sabnis Dushyantrao, C.; Khairnar, P.; Simran; Phatale, V.; Pandey, G.; Srivastava, S.; Kumar, S. Paradigm of Lyotropic Liquid Crystals in Tissue Regeneration. International Journal of Pharmaceutics 2023, 634, 122633. https://doi.org/10.1016/j.ijpharm.2023.122633
  31. Charankumar, K.; Bagasariya, D.; Jain, N.; Famta, P.; Shah, S.; Vambhurkar, G.; Fernandes, V.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design (QbD) Abetted Development of Pioglitazone Incorporated Liposomes-Loaded Hyaluronic Acid-Based In Situ Hydrogel for the Management of Melanoma. Journal of Drug Delivery Science and Technology 2023, 84, 104453. https://doi.org/10.1016/j.jddst.2023.104453
  32. Bagasariya, D.; Charankumar, K.; Shah, S.; Famta, P.; Fernandes, V.; Shahrukh, S.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design Endorsed Atorvastatin-Loaded Nanostructured Lipid Carriers Embedded in pH-Responsive Gel for Melanoma. Journal of Microencapsulation 2023. https://doi.org/10.1080/02652048.2023.2282971
  33. Mohd Ateeq, M. A.; Aalhate, M.; Mahajan, S.; Gupta, U.; Maji, I.; Khaparkhuntikar, K.; Dhuri, A.; Mohan, N. C.; Srivastava, S.; Singh, P. K. Nanocarrier-Mediated Delivery for Targeting Stomach Cancer. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy 2023, 257–302. https://doi.org/10.1016/B978-0-323-95303-0.00006-X
  34. Atmakuri, S.; Nene, S.; Jain, H.; Joga, R.; Devabattula, G.; Godugu, C.; Srivastava, S. Topical Delivery of Tofacitinib Citrate Loaded Novel Nanoemulgel for the Management of 2,4-Dichlorodinitrobenzene Induced Atopic Dermatitis in Mice Model. Journal of Drug Delivery Science and Technology 2023, 80, 104145. https://doi.org/10.1016/j.jddst.2022.104145
  35. Rathour, D.; Shah, S.; Khan, S.; Singh, P. K.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Role of Gut Microbiota in Depression: Understanding Molecular Pathways, Recent Research, and Future Direction. Behavioural Brain Research 2023, 436, 114081. https://doi.org/10.1016/j.bbr.2022.114081
  36. Jain, N.; Srinivasarao, D. A.; Famta, P.; Shah, S.; Vambhurkar, G.; Shahrukh, S.; Singh, S. B.; Srivastava, S. The Portrayal of Macrophages as Tools and Targets: A Paradigm Shift in Cancer Management. Life Sciences 2023, 316, 121399. https://doi.org/10.1016/j.lfs.2023.121399
  37. Pinjala, P.; Tryphena, K. P.; Prasad, R.; Khatri, D. K.; Sun, W.; Singh, S. B.; Gugulothu, D.; Srivastava, S.; Vora, L. CRISPR/Cas9 Assisted Stem Cell Therapy in Parkinson’s Disease. Biomaterials Research 2023, 27. https://doi.org/10.1186/s40824-023-00381-y
  38. Amulya, E.; Sikder, A.; Vambhurkar, G.; Shah, S.; Khatri, D. K.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Nanomedicine Based Strategies for Oligonucleotide Traversion Across the Blood–Brain Barrier. Journal of Controlled Release 2023, 354, 554–571. https://doi.org/10.1016/j.jconrel.2023.01.031
  39. Famta, P.; Shah, S.; Vambhurkar, G.; Srinivasarao, D. A.; Jain, N.; Begum, N.; Sharma, A.; Shahrukh, S.; Kumar, K. C.; Bagasariya, D.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design Endorsed Fabrication of Ibrutinib-Loaded Human Serum Albumin Nanoparticles for the Management of Leukemia. European Journal of Pharmaceutics and Biopharmaceutics 2023, 190, 94–106. https://doi.org/10.1016/j.ejpb.2023.07.008
  40. Phatale, V.; Famta, P.; Srinivasarao, D. A.; Vambhurkar, G.; Jain, N.; Pandey, G.; Kolipaka, T.; Khairnar, P.; Shah, S.; Singh, S. B.; Raghuvanshi, R. S.; Srivastava, S. Neutrophil Membrane-Based Nanotherapeutics: Propitious Paradigm Shift in the Management of Cancer. Life Sciences 2023, 331, 122021. https://doi.org/10.1016/j.lfs.2023.122021
  41. Shah, S.; Famta, P.; Srinivasarao, D. A.; Shahrukh, S.; Jain, N.; Vambhurkar, G.; Singh, S. B.; Srivastava, S. Unravelling the Potential of Microbots in Cancer Therapy. Applied Materials Today 2023, 34, 101887. https://doi.org/10.1016/j.apmt.2023.101887
  42. Kolipaka, T.; Khairnar, P.; Phatale, V.; Pandey, G.; Famta, P.; Shah, S.; Asthana, A.; Nanduri, S.; Raghuvanshi, R. S.; Srivastava, S. Multifaceted Roles of Pollen in the Management of Cancer. International Journal of Pharmaceutics 2023, 643, 123278. https://doi.org/10.1016/j.ijpharm.2023.123278
  43. Shahrukh, S.; Jain, N.; Shah, S.; Famta, P.; Srinivasarao, D. A.; Khatri, D. K.; Asthana, A.; Singh, S. B.; Raghuvanshi, R. S.; Srivastava, S. Aptamer Guided Nanomedicine Strategies in Prostate Cancer: Targeting and Diagnosis. Journal of Drug Delivery Science and Technology 2023, 85, 104593. https://doi.org/10.1016/j.jddst.2023.104593
  44. Shah, S.; Famta, P.; Shahrukh, S.; Jain, N.; Vambhurkar, G.; Srinivasarao, D. A.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Multifaceted Applications of Ulvan Polysaccharides: Insights on Biopharmaceutical Avenues. International Journal of Biological Macromolecules 2023, 234, 123669. https://doi.org/10.1016/j.ijbiomac.2023.123669
  45. Jain, R.; Begum, N.; Tryphena, K. P.; Singh, S. B.; Srivastava, S.; Rai, S. N.; Vamanu, E.; Khatri, D. K. Inter and Intracellular Mitochondrial Transfer: Future of Mitochondrial Transplant Therapy in Parkinson’s Disease. Biomedicine & Pharmacotherapy 2023, 159, 114268. https://doi.org/10.1016/j.biopha.2023.114268
  46. Khan, S. S.; Janrao, S.; Srivastava, S.; Singh, S. B.; Vora, L.; Khatri, D. K. GSK-3β: An Exuberating Neuroinflammatory Mediator in Parkinson’s Disease. Biochemical Pharmacology 2023, 210, 115496. https://doi.org/10.1016/j.bcp.2023.115496
  47. Tryphena, K. P.; Singh, G.; Jain, N.; Famta, P.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Integration of miRNA’s Theranostic Potential with Nanotechnology: Promises and Challenges for Parkinson’s Disease Therapeutics. Mechanisms of Ageing and Development 2023, 211, 111800. https://doi.org/10.1016/j.mad.2023.111800
  48. Naren, P.; Samim, K. S.; Tryphena, K. P.; Vora, L. K.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Microtubule Acetylation Dyshomeostasis in Parkinson’s Disease. Translational Neurodegeneration 2023, 12. https://doi.org/10.1186/s40035-023-00354-0
  49. Pathade, V.; Nene, S.; Ratnam, S.; Khatri, D. K.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Emerging Insights of Peptide-Based Nanotherapeutics for Effective Management of Rheumatoid Arthritis. Life Sciences 2023, 312, 121257. https://doi.org/10.1016/j.lfs.2022.121257
  50. Famta, P.; Shah, S.; Jain, N.; Srinivasarao, D. A.; Murthy, A.; Ahmed, T.; Vambhurkar, G.; Shahrukh, S.; Singh, S. B.; Srivastava, S. Albumin-Hitchhiking: Fostering the Pharmacokinetics and Anticancer Therapeutics. Journal of Controlled Release 2023, 353, 166–185. https://doi.org/10.1016/j.jconrel.2022.11.034
  51. Jain, N.; Shahrukh, S.; Famta, P.; Shah, S.; Vambhurkar, G.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Immune Cell–Camouflaged Surface-Engineered Nanotherapeutics for Cancer Management. Acta Biomaterialia 2023, 155, 57–79. https://doi.org/10.1016/j.actbio.2022.11.001
  52. Ommi, O.; Chilvery, S.; Dhopat, P. S.; Sharma, A.; Bhalerao, H. A.; Dannaram, S. R.; Nanduri, S.; Sonti, R.; Godugu, C.; Yaddanapudi, V. M. Exploration of Quinoxaline-Benzimidazole Hybrids as Apoptosis-Inducing Agents and Tubulin Polymerisation Inhibitors. Journal of Molecular Structure 2023, 1292, 136184. https://doi.org/10.1016/j.molstruc.2023.136184
  53. Ojaswitha; Paoletti, N.; Bonardi, A.; Gratteri, P.; Bhalerao, H. A.; Sau, S.; Nanduri, S.; Mohammed, A.; Kalia, N. P.; Sonti, R.; Yaddanapudi, V. M. Exploration of 3-Aryl Pyrazole-Tethered Sulfamoyl Carboxamides as Carbonic Anhydrase Inhibitors. Archiv der Pharmazie 2023, 356, 2300309. https://doi.org/10.1002/ardp.202300309
  54. Dhurjad, P.; Gupta, K.; Sakla, A. P.; Shankaraiah, N.; Sonti, R. A Validated High-Performance Liquid Chromatography Method for the Determination of Brassinin, an Indoleamine 2,3-Dioxygenase Inhibitor in Rat Plasma. Separation Science Plus 2023, 6, 2300073. https://doi.org/10.1002/sscp.202300073
  55. Shekh, S.; Dhurjad, P.; Vijayasarathy, M.; Dolle, A.; Dhannura, S.; Sahoo, D. K.; Sonti, R.; Gowd, K. H. Oxidative Folding Catalysts of Conotoxins Derived from the Venom Duct Transcriptome of C. frigidus and C. amadis. Biochemistry 2023, 62, 3061. https://doi.org/10.1021/acs.biochem.3c00320
  56. Reddy, G. N.; Jogvanshi, A.; Naikwadi, S.; Sonti, R. Nirmatrelvir and Ritonavir Combination: An Antiviral Therapy for COVID-19. Expert Review of Anti-infective Therapy 2023, 21, 943. https://doi.org/10.1080/14787210.2023.2241638
  57. Yakkala, P. A.; Khan, I. A.; Dannarm, S. R.; Aboti, J.; Sonti, R.; Shafi, S.; Kamal, A. Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1,3,4-Oxadiazoles via Smiles Rearrangement. The Journal of Organic Chemistry 2023, 88, 12216. https://doi.org/10.1021/acs.joc.3c00516
  58. Gajula, S. N. R.; Talari, S.; Nathani, T. N.; Munjal, V.; Rahman, Z.; Dandekar, M. P.; Sonti, R. Effect of Chronopharmacology and Food on In Vivo Pharmacokinetic Profile of Mavacamten. Bioanalysis 2023, 15, 695. https://doi.org/10.4155/bio-2023-0030
  59. Gajula, S. N. R.; Godugu, C.; Sonti, R. Chronopharmacokinetics: A Critical Missing Step in Drug Discovery and Development. Bioanalysis 2023. https://doi.org/10.4155/bio-2023-0080
  60. Gajula, S. N. R.; Talari, S.; Chilvery, S.; Godugu, C.; Sonti, R. A Unique In Vivo Pharmacokinetic Profile, In Vitro Metabolic Stability and Hepatic First-Pass Metabolism of Garcinol, a Promising Novel Anticancer Phytoconstituent, by Liquid Chromatography–Mass Spectrometry. RPS Pharmacy and Pharmacology Reports 2023, 2, 2. https://doi.org/10.1093/rpsppr/rqad017
  61. Gajula, S. N. R.; Khairnar, A. S.; Jock, P.; Kumari, N.; Pratima, K.; Munjal, V.; Kalan, P.; Sonti, R. LC-MS/MS: A Sensitive and Selective Analytical Technique to Detect COVID-19 Protein Biomarkers in the Early Disease Stage. Expert Review of Proteomics 2023, 1. https://doi.org/10.1080/14789450.2023.2191845
  62. Dhurjad, P.; Jaiswal, P.; Gupta, K.; Wanjari, P.; Sonti, R. Mass Spectrometry: A Key Tool in Anti-Doping. Separation Science Plus 2023, 6. https://doi.org/10.1002/sscp.202200058
  63. Sana, S.; Dannarm, S. R.; Tokala, R.; Dastari, S.; Sathish, M.; Kumar, R.; Sonti, R.; Shankaraiah, N. Sustainable Photocatalytic C–H Annulation of Heteroarenes with Sulfoxonium Ylides: Synthesis and Photophysical Properties of Fused Imidazo[1,2-a]Pyridine-Based Molecules. Organic Chemistry Frontiers 2023, 10, 4800. https://doi.org/10.1039/d3qo00923h
  64. Sana, S.; Dastari, S.; Dannarm, S. R.; Tokala, R.; Sathish, M.; Sonti, R.; Shankaraiah, N. Visible-Light-Mediated Photocatalytic Sequential N-Arylation: An Eco-Friendly Synthetic Route to Unsymmetrical Diarylamines and the Imatinib Drug. Organic Chemistry Frontiers 2023, 10, 4573. https://doi.org/10.1039/d3qo00894k
  65. Ommi, O.; Ahmad, M. N.; Gajula, S. N. R.; Wanjari, P.; Sau, S.; Agnivesh, P. K.; Sahoo, S. K.; Kalia, N. K.; Sonti, R.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Synthesis and Pharmacological Evaluation of 1,3-Diaryl Substituted Pyrazole Based (Thio)Urea Derivatives as Potent Antimicrobial Agents Against Multi-Drug Resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Medicinal Chemistry 2023, 14, 1296. https://doi.org/10.1039/d3md00079f
  66. Makhal, P. N.; Dannarm, S. R.; Shaikh, A. S.; Ahmed, R.; Chilvery, S.; Dayare, L. N.; Sonti, R.; Godugu, C.; Kaki, V. R. Exo-Trig Selenocyclization of Secondary Allylic Carboxamides Using Woollins’ Reagent: En Route to 2,5-Disubstituted Selenazolines. Chemical Communications 2023, 59, 3767. https://doi.org/10.1039/d2cc06782j
  67. Satti, S.; Palepu, M. S. K.; Singh, A. A.; Jaiswal, Y.; Dash, S. P.; Gajula, S. N. R.; Chaganti, S.; Samanthula, G.; Sonti, R.; Dandekar, M. P. Anxiolytic- and Antidepressant-Like Effects of Bacillus coagulans Unique IS-2 Mediate via Reshaping of Microbiome Gut-Brain Axis in Rats. Neurochemistry International 2023, 105483. https://doi.org/10.1016/j.neuint.2023.105483
  68. Mukhopadhyay, N.; Shukla, A.; Makhal, P. N.; Kaki, V. R. Natural Product-Driven Dual COX-LOX Inhibitors: Overview of Recent Studies on the Development of Novel Anti-Inflammatory Agents. Heliyon 2023, 9 (3), e14569.
  69. Shaikh, A. S.; Sethi, A.; Makhal, P. N.; Rathi, B.; Kaki, V. R. Quest for Selective MMP9 Inhibitors: A Computational Approach. Journal of Biomolecular Structure and Dynamics 2023, 41 (24), 15053–15066.
  70. Makhal, P. N.; Sood, A.; Shaikh, A. S.; Dayare, L. N.; Khatri, D. K.; Kaki, V. R. Development of Trisubstituted Thiophene-3-Carboxamide Selenide Derivatives as Novel EGFR Kinase Inhibitors with Cytotoxic Activity. RSC Medicinal Chemistry 2023, 14, 2677–2698.
  71. Makhal, P. N.; Dannarm, S. R.; Shaikh, A. S.; Ahmed, R.; Chilvery, S.; Dayare, L. N.; Sonti, R.; Godugu, C.; Kaki, V. R. Exo-trig Selenocyclization of Secondary Allylic Carboxamides Using Woollins’ Reagent: En Route to 2,5-Disubstituted Selenazolines. Chemical Communications 2023, 59 (25), 3767–3770.
  72. Tentu, P. M.; Bazaz, M. R.; Pasam, T.; Shaikh, A. S.; Rahman, Z.; Mourya, A.; Kaki, V. R.; Madan, J.; Dandekar, M. P. Oxyberberine, an Oxoderivative of Berberine, Confers Neuroprotective Effects in Controlled-Cortical Impact Mouse Model of Traumatic Brain Injury. International Journal of Neuroscience 2023, December, 1–16.
  73. Katta, C.; Shaikh, A. S.; Bhale, N.; Jyothi, V. G. S. S.; Kaki, V. R.; Dikundwar, A. G.; Singh, P. K.; Shukla, R.; Mishra, K.; Madan, J. Naringenin-Capped Silver Nanoparticles Amalgamated Gel for the Treatment of Cutaneous Candidiasis. AAPS PharmSciTech 2023, 24 (5), 126.